Pelican Therapeutics Overview
- Year Founded
-
2009

- Status
-
Acquired/Merged
- Employees
-
3

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$225K
- Investors
-
2
Pelican Therapeutics General Information
Description
Developer of therapeutics biological agents designed to focus on targeting exciting immuno-oncology combinations and enhance them. The company offers humanized monoclonal antibody, human fusion protein and other antibodies that are a class of T (lymphocyte ) cell that is responsible for eliminating tumor and cancer cells in patients, enabling patients to fight diseases more efficiently.
Contact Information
Website
www.pelicantherapeutics.com(Operating Subsidiary)
Corporate Office
- 1305 East Houston Street
- Suite 210
- San Antonio, TX 78205
- United States
Corporate Office
- 1305 East Houston Street
- Suite 210
- San Antonio, TX 78205
- United States
Pelican Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Grant | 07-Jan-2020 | $225K | Completed | Startup | ||
4. Merger/Acquisition | 28-Apr-2017 | Completed | Startup | |||
3. Grant | 19-May-2016 | Completed | Startup | |||
2. Angel (individual) | 18-Aug-2015 | $250K | $410K | Completed | Startup | |
1. Angel (individual) | 06-Jun-2014 | $160K | $160K | Completed | Startup |
Pelican Therapeutics Comparisons
Industry
Financing
Details
Pelican Therapeutics Competitors (70)
One of Pelican Therapeutics’s 70 competitors is Marker Therapeutics, a Formerly VC-backed company based in Houston, TX.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Marker Therapeutics | Formerly VC-backed | Houston, TX | ||||
Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
Gadeta | Formerly VC-backed | Utrecht, Netherlands |
Pelican Therapeutics Patents
Pelican Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3151319-A1 | Tnfrsf25-mediated treatments of immune diseases and disorders | Pending | 26-Sep-2019 | ||
US-20220340672-A1 | Tnfrsf25-mediated treatments of immune diseases and disorders | Pending | 26-Sep-2019 | ||
EP-4034563-A1 | Tnfrsf25-mediated treatments of immune diseases and disorders | Inactive | 26-Sep-2019 | ||
EP-4034563-A4 | Tnfrsf25-mediated treatments of immune diseases and disorders | Inactive | 26-Sep-2019 | ||
US-20220298252-A1 | Methods of treating cancer using tnfrsf25 antibodies | Pending | 30-Aug-2019 | C07K16/2878 |
Pelican Therapeutics Signals
Pelican Therapeutics FAQs
-
When was Pelican Therapeutics founded?
Pelican Therapeutics was founded in 2009.
-
Where is Pelican Therapeutics headquartered?
Pelican Therapeutics is headquartered in San Antonio, TX.
-
What is the size of Pelican Therapeutics?
Pelican Therapeutics has 3 total employees.
-
What industry is Pelican Therapeutics in?
Pelican Therapeutics’s primary industry is Biotechnology.
-
Is Pelican Therapeutics a private or public company?
Pelican Therapeutics is a Private company.
-
What is Pelican Therapeutics’s current revenue?
The current revenue for Pelican Therapeutics is
. -
How much funding has Pelican Therapeutics raised over time?
Pelican Therapeutics has raised $410K.
-
Who are Pelican Therapeutics’s competitors?
Marker Therapeutics, Kite Pharma, Intellia Therapeutics, Carisma Therapeutics, and Gadeta are some of the 70 competitors of Pelican Therapeutics.
-
When was Pelican Therapeutics acquired?
Pelican Therapeutics was acquired on 07-Jan-2020.
-
Who acquired Pelican Therapeutics?
Pelican Therapeutics was acquired by Scorpius Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »